Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 25

1.

Melanocytic colonization of choroid plexus papilloma: A previously undocumented source of pigment storage in the plexogenic epithelium.

Egervari K, Lobrinus JA, Merkler D, Vajtai I.

Clin Neuropathol. 2019 Sep/Oct;38(5):249-252. doi: 10.5414/NP301200. No abstract available.

PMID:
31296285
2.

Brain-resident memory T cells generated early in life predispose to autoimmune disease in mice.

Steinbach K, Vincenti I, Egervari K, Kreutzfeldt M, van der Meer F, Page N, Klimek B, Rossitto-Borlat I, Di Liberto G, Muschaweckh A, Wagner I, Hammad K, Stadelmann C, Korn T, Hartley O, Pinschewer DD, Merkler D.

Sci Transl Med. 2019 Jun 26;11(498). pii: eaav5519. doi: 10.1126/scitranslmed.aav5519.

PMID:
31243152
3.

Neurons under T Cell Attack Coordinate Phagocyte-Mediated Synaptic Stripping.

Di Liberto G, Pantelyushin S, Kreutzfeldt M, Page N, Musardo S, Coras R, Steinbach K, Vincenti I, Klimek B, Lingner T, Salinas G, Lin-Marq N, Staszewski O, Costa Jordão MJ, Wagner I, Egervari K, Mack M, Bellone C, Blümcke I, Prinz M, Pinschewer DD, Merkler D.

Cell. 2018 Oct 4;175(2):458-471.e19. doi: 10.1016/j.cell.2018.07.049. Epub 2018 Aug 30.

4.

Concurrent IDH1 and SMARCB1 Mutations in Pediatric Medulloblastoma: A Case Report.

El-Ayadi M, Egervari K, Merkler D, McKee TA, Gumy-Pause F, Stichel D, Capper D, Pietsch T, Ansari M, von Bueren AO.

Front Neurol. 2018 Jun 19;9:398. doi: 10.3389/fneur.2018.00398. eCollection 2018.

5.

Developmental and oncogenic programs in H3K27M gliomas dissected by single-cell RNA-seq.

Filbin MG, Tirosh I, Hovestadt V, Shaw ML, Escalante LE, Mathewson ND, Neftel C, Frank N, Pelton K, Hebert CM, Haberler C, Yizhak K, Gojo J, Egervari K, Mount C, van Galen P, Bonal DM, Nguyen QD, Beck A, Sinai C, Czech T, Dorfer C, Goumnerova L, Lavarino C, Carcaboso AM, Mora J, Mylvaganam R, Luo CC, Peyrl A, Popović M, Azizi A, Batchelor TT, Frosch MP, Martinez-Lage M, Kieran MW, Bandopadhayay P, Beroukhim R, Fritsch G, Getz G, Rozenblatt-Rosen O, Wucherpfennig KW, Louis DN, Monje M, Slavc I, Ligon KL, Golub TR, Regev A, Bernstein BE, Suvà ML.

Science. 2018 Apr 20;360(6386):331-335. doi: 10.1126/science.aao4750.

6.

Perturbed Wnt signaling leads to neuronal migration delay, altered interhemispheric connections and impaired social behavior.

Bocchi R, Egervari K, Carol-Perdiguer L, Viale B, Quairiaux C, De Roo M, Boitard M, Oskouie S, Salmon P, Kiss JZ.

Nat Commun. 2017 Oct 27;8(1):1158. doi: 10.1038/s41467-017-01046-w.

7.

Astrocytes spatially restrict VEGF signaling by polarized secretion and incorporation of VEGF into the actively assembling extracellular matrix.

Egervari K, Potter G, Guzman-Hernandez ML, Salmon P, Soto-Ribeiro M, Kastberger B, Balla T, Wehrle-Haller B, Kiss JZ.

Glia. 2016 Mar;64(3):440-56. doi: 10.1002/glia.22939. Epub 2015 Nov 5.

8.

Wnt signaling regulates multipolar-to-bipolar transition of migrating neurons in the cerebral cortex.

Boitard M, Bocchi R, Egervari K, Petrenko V, Viale B, Gremaud S, Zgraggen E, Salmon P, Kiss JZ.

Cell Rep. 2015 Mar 3;10(8):1349-61. doi: 10.1016/j.celrep.2015.01.061. Epub 2015 Feb 26.

9.

Secretion of VEGF-165 has unique characteristics, including shedding from the plasma membrane.

Guzmán-Hernández ML, Potter G, Egervári K, Kiss JZ, Balla T.

Mol Biol Cell. 2014 Apr;25(7):1061-72. doi: 10.1091/mbc.E13-07-0418. Epub 2014 Feb 5.

10.

Correlation among metallothionein expression, intratumoural macrophage infiltration and the risk of metastasis in human cutaneous malignant melanoma.

Emri E, Egervari K, Varvolgyi T, Rozsa D, Miko E, Dezso B, Veres I, Mehes G, Emri G, Remenyik E.

J Eur Acad Dermatol Venereol. 2013 Mar;27(3):e320-7. doi: 10.1111/j.1468-3083.2012.04653.x. Epub 2012 Jul 23.

PMID:
22817475
11.

Aurora kinase B expression in breast carcinoma: cell kinetic and genetic aspects.

Hegyi K, Egervári K, Sándor Z, Méhes G.

Pathobiology. 2012;79(6):314-22. doi: 10.1159/000338082. Epub 2012 Jun 9.

12.

Impact of chromosome 17 centromere region assessment on HER2 status reported in breast cancer.

Egervari K, Kosa C, Szollosi Z.

Pathol Res Pract. 2011 Aug 15;207(8):468-71. doi: 10.1016/j.prp.2011.05.008. Epub 2011 Jul 7.

PMID:
21741182
13.

Intraoperative evaluation of sentinel lymph nodes in breast cancer: comparison of frozen sections, imprint cytology and immunocytochemistry.

Francz M, Egervari K, Szollosi Z.

Cytopathology. 2011 Feb;22(1):36-42. doi: 10.1111/j.1365-2303.2010.00818.x. Epub 2010 Oct 26.

PMID:
20977506
14.

Comparison of Pathvysion and Poseidon HER2 FISH assays in measuring HER2 amplification in breast cancer: a validation study.

Francz M, Egervari K, Kardos L, Toth J, Nemes Z, Szanto J, Szollosi Z.

J Clin Pathol. 2010 Apr;63(4):341-6. doi: 10.1136/jcp.2009.066852. Epub 2009 Dec 3.

PMID:
19965795
15.

FISH and immunohistochemical status of the hepatocyte growth factor receptor (c-Met) in 184 invasive breast tumors.

Carracedo A, Egervari K, Salido M, Rojo F, Corominas JM, Arumi M, Corzo C, Tusquets I, Espinet B, Rovira A, Albanell J, Szollosi Z, Serrano S, Solé F.

Breast Cancer Res. 2009;11(2):402. doi: 10.1186/bcr2239. Epub 2009 Apr 21. No abstract available.

16.

An alternative and reliable real-time quantitative PCR method to determine HER2/neu amplification in breast cancer.

Egervari K, Toth J, Nemes Z, Szollosi Z.

Appl Immunohistochem Mol Morphol. 2009 May;17(3):247-54. doi: 10.1097/PAI.0b013e3181907a60.

PMID:
19098680
17.

Analysis of EGFR gene amplification, protein over-expression and tyrosine kinase domain mutation in recurrent glioblastoma.

Toth J, Egervari K, Klekner A, Bognar L, Szanto J, Nemes Z, Szollosi Z.

Pathol Oncol Res. 2009 Jun;15(2):225-9. doi: 10.1007/s12253-008-9082-4. Epub 2008 Aug 28.

PMID:
18752056
18.
19.

Immunohistochemical antibodies in breast cancer HER2 diagnostics. A comparative immunohistochemical and fluorescence in situ hybridization study.

Egervari K, Szollosi Z, Nemes Z.

Tumour Biol. 2008;29(1):18-27. doi: 10.1159/000132567. Epub 2008 May 23.

PMID:
18497545
20.

Tissue microarray technology in breast cancer HER2 diagnostics.

Egervari K, Szollosi Z, Nemes Z.

Pathol Res Pract. 2007;203(3):169-77. Epub 2007 Feb 9.

PMID:
17292562
21.

Reply to "IHC for Her2 with CBE356 antibody is a more accurate predictor of Her2 gene amplification by FISH than HercepTest in breast carcinoma".

Egervari K, Szollosi Z, Nemes Z.

J Clin Pathol. 2006 Jun;59(6):665; author reply 665-6. No abstract available.

22.
23.

Comparison of immunohistochemical and fluorescence in situ hybridization assessment of HER-2 status in routine practice.

Egervari K, Szollosi Z, Nemes Z, Kaczur V.

Am J Clin Pathol. 2006 Jan;125(1):155-6. No abstract available.

PMID:
16483004
24.
25.

Re: Lottner et al. simultaneous detection of HER2/neu gene amplification and protein overexpression in paraffin-embedded breast cancer. J Pathol 2005; 205: 577-584.

Szollosi Z, Egervari K, Nemes Z, Kaczur V.

J Pathol. 2005 Sep;207(1):119-20; author reply 121-2. No abstract available.

PMID:
15920704

Supplemental Content

Loading ...
Support Center